Expiration date: 06/2026
Active substance: ethylmethylhydroxypyridine succinate)
Pharmacological action
Mexidol ® FORTE 250 is an inhibitor of free radical processes, a membrane protector with antihypoxic, stress-protective, nootropic, antiepileptic and anxiolytic effects. It belongs to the class of 3-hydroxypyridines.
Indications of the drug Mexidol ® Forte 250
- consequences of acute cerebral circulatory disorders, including after transient ischemic attacks, in the subcompensation phase (as preventive courses);
- mild traumatic brain injury, consequences of traumatic brain injuries;
- encephalopathies of various origins (dyscirculatory, dysmetabolic, post-traumatic, mixed);
- the syndrome of vegetative dystonia;
- mild cognitive disorders of atherosclerotic origin;
- anxiety disorders in neurotic and neurosis-like conditions;
- Coronary artery disease (in the complex therapy);
- relief of withdrawal syndrome in alcoholism with a predominance of neurosis-like and vegetative-vascular disorders, post-withdrawal disorders;
- conditions after acute intoxication with antipsychotic drugs;
- asthenic conditions, as well as for the prevention of the development of somatic diseases under the influence of extreme factors and loads;
- the impact of extreme (stressful) factors.
The dosage regimen
The inside of 250 mg 3 times/day.
The initial dose is 250 mg (1 tab.) 1-2 times/day with a gradual increase until a therapeutic effect is obtained; the maximum daily dose is 750 mg (3 tab.).
The duration of treatment is 2-6 weeks; for the relief of alcohol withdrawal-5-7 days. The duration of the course of therapy in patients with CHD is not less than 1.5-2 months.
Repeated courses (on the recommendation of a doctor), it is advisable to conduct in the spring and autumn periods.
Contraindications to use
- acute disorders of liver and kidney function;
- increased individual sensitivity to the drug.
Due to insufficient knowledge of the drug's action - childhood, pregnancy, breastfeeding.
Use during pregnancy and lactation
Mexidol ® FORTE 250 is contraindicated during pregnancy and during (breastfeeding).
Use in children
The use of the drug in childhood is contraindicated due to insufficient knowledge of the drug's action.